5. Goodwill and Intangible Assets

In 2025, 2024, and 2023, the Company performed a quantitative assessment of all reporting units as of October 1. We utilized a combination of the discounted cash flow analysis or “income approach” (50%) and the “market approach” (50%).

Our 2025, 2024, and 2023 goodwill impairment analyses concluded that the fair values of all reporting units were in excess of their carrying amounts. Subsequent to completing our goodwill impairment tests, no further indicators of impairment were identified. Based on these analyses, we recorded no goodwill impairment for the years ended December 31, 2025, 2024, and 2023.

The determination of whether the carrying value of the reporting unit exceeds its fair value involves a high degree of estimation and can be affected by a number of industry and company-specific risk factors that are subject to change over time. If actual performance does not achieve the projections, or if the assumptions used change in the future, we may be required to recognize additional impairment charges in future periods.

A summary of changes to goodwill is as follows (in thousands):

 

 

Goodwill

 

 

Pharmacy Solutions

 

 

Provider Services

 

 

Total

 

Goodwill at January 1, 2024*

 

$

833,989

 

 

$

1,466,783

 

 

$

2,300,772

 

Goodwill added through acquisitions

 

 

7,063

 

 

 

56,144

 

 

 

63,207

 

Measurement period adjustments

 

 

 

 

 

237

 

 

 

237

 

Foreign currency adjustments

 

 

 

 

 

(332

)

 

 

(332

)

Goodwill at December 31, 2024*

 

$

841,052

 

 

$

1,522,832

 

 

$

2,363,884

 

Goodwill added through acquisitions

 

 

 

 

 

181,472

 

 

 

181,472

 

Measurement period adjustments

 

 

 

 

 

128

 

 

 

128

 

Foreign currency adjustments

 

 

 

 

 

189

 

 

 

189

 

Goodwill at December 31, 2025*

 

$

841,052

 

 

$

1,704,621

 

 

$

2,545,673

 

 

 

 

 

 

 

 

 

 

 

* For the periods presented, the carrying amount of goodwill is presented net of accumulated impairment losses of $40.9 million, which were incurred in fiscal year 2022.

 

 

Intangible assets are as follows (in thousands):

 

 

December 31, 2025

 

 

December 31, 2024

 

 

 

 

Gross

 

 

Accumulated
Amortization

 

 

Net Carrying
Value

 

 

Gross

 

 

Accumulated
Amortization

 

 

Net Carrying
Value

 

 

Life
(Years)

Customer relationships

 

$

502,160

 

 

$

356,146

 

 

$

146,014

 

 

$

542,137

 

 

$

335,647

 

 

$

206,490

 

 

5-20

Trade names

 

 

318,768

 

 

 

154,601

 

 

 

164,167

 

 

 

332,977

 

 

 

140,020

 

 

 

192,957

 

 

2-20

Licenses

 

 

67,395

 

 

 

18,886

 

 

 

48,509

 

 

 

68,425

 

 

 

17,528

 

 

 

50,897

 

 

10-20

Doctor/payor network

 

 

5,650

 

 

 

4,987

 

 

 

663

 

 

 

12,730

 

 

 

10,965

 

 

 

1,765

 

 

5-8

Covenants not to compete

 

 

6,654

 

 

 

4,717

 

 

 

1,937

 

 

 

8,790

 

 

 

5,886

 

 

 

2,904

 

 

2-7

Other intangible assets

 

 

10,940

 

 

 

7,925

 

 

 

3,015

 

 

 

10,940

 

 

 

6,362

 

 

 

4,578

 

 

5-7

Total definite-lived assets

 

$

911,567

 

 

$

547,262

 

 

$

364,305

 

 

$

975,999

 

 

$

516,408

 

 

$

459,591

 

 

 

Licenses

 

 

193,250

 

 

 

 

 

 

193,250

 

 

 

135,633

 

 

 

 

 

 

135,633

 

 

Indefinite

Total intangible assets

 

$

1,104,817

 

 

$

547,262

 

 

$

557,555

 

 

$

1,111,632

 

 

$

516,408

 

 

$

595,224

 

 

 

 

Amortization expense for the years ended December 31, 2025, 2024, and 2023 was $91.1 million, $95.3 million, and $103.3 million, respectively.

As of December 31, 2025, total estimated amortization expense for the Company’s definite-lived intangible assets for the next five years and thereafter is as follows (in thousands):

 

2026

 

$

79,888

 

2027

 

 

46,935

 

2028

 

 

39,876

 

2029

 

 

34,000

 

2030

 

 

33,108

 

Thereafter

 

 

130,498

 

 

$

364,305

 

 

Historical Timeline

Fiscal YearFiled
2025Feb 27, 2026Showing above
2024Mar 6, 2025

About Goodwill & Intangibles Disclosures

Goodwill and intangible asset disclosures reveal the premium paid in acquisitions and how management assesses whether that premium retains its value. Since goodwill is no longer amortized under US GAAP, the annual impairment test is the only mechanism that adjusts carrying values downward — making the assumptions behind that test critically important for investors.

Key signals: a history of goodwill impairments suggests management consistently overpays for acquisitions. Watch the gap between reporting unit fair value and carrying amount — when fair value exceeds carrying amount by less than 10-20%, a small decline in business performance could trigger a write-down. For finite-lived intangibles, examine useful life assumptions across customer relationships, technology, and trade names; aggressive estimates inflate near-term earnings. Compare total intangibles-to-total-assets ratios against peers to assess acquisition dependency. Rising goodwill as a percentage of equity can signal balance sheet fragility.